Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators

Circulation: Cardiovascular Imaging

Volumn 4, Issue 6, 2011, Pages 662-670

  Sasaki, Takeshi ^a,c   Hansford, Rozann ^a   Zviman, Menekhem M ^a   Kolandaivelu, Aravindan ^a   Bluemke, David A ^b   Berger, Ronald D ^a   Calkins, Hugh ^a   Halperin, Henry R ^a   Nazarian, Saman ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Artifacts; Implantable cardioverter defibrillator; MRI; Pacemakers

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; ARTIFACT; BIVENTRICULAR ASSIST DEVICE; CARDIOVASCULAR MAGNETIC RESONANCE; CINERADIOGRAPHY; DEFIBRILLATOR; FEMALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PACEMAKER; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; ARTIFACTS; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; EVALUATION STUDIES AS TOPIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 82955173680     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.111.965764     Document Type: Article

References (28)

1. Nazarian S. Roguin A, Zviman MM, Lardo AC, Dickfeld TL, Calkins H, Weiss RG, Berger RD, Bluemke DA, Halperin HR. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent PMs and ICDs at 1.5 Tesla. Circulation. 2006;114: 1277-1284. (Pubitemid 44402053)
2. Roguin A, Zviman MM, Meininger GR, Rodrigues ER, Dickfeld TM, Bluemke DA, Lardo A, Berger RD, Calkins H, Halperin HR. Modern PM and ICD systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation. 2004;110: 475-482. (Pubitemid 39031161)
3. Nazarian S, Halperin HR. How to perform magnetic resonance imaging on patients with implantable cardiac arrhythmia devices. Heart Rhythm. 2009;6:138-143.
4. Pulver AF, Puchalski MD, Bradley DJ, Minich LL, SU JT, Saarel EV, Whitaker P, Etheridge SP. Safety and imaging quality of MRI in pediatric and adult congenital heart disease patients with PMs. Pacing Clin Electrophysiol. 2009;32:450-456.
5. Naehle CP, Strach K, Thomas D, Meyer C, Linhart M, Bitaraf S, Litt H, Schwab JO, Schild H, Sommer T. Magnetic resonance imaging at 1.5-T in patients with ICDs. J Am Coll Cardiol. 2009;54:549-555.
6. Tian J, Smith MF, Jeudy J, Dickfeld T. Multimodality fusion imaging using delayed-enhanced cardiac magnetic resonance imaging, computed tomography, positron emission tomography, and real-time intracardiac echocardiography to guide ventricular tachycardia ablation in ICD patients. Heart Rhythm. 2009;6:825-828.
7. Roguin A, Donahue JK, Bomma CS, Bluemke DA, Halperin HR. Cardiac magnetic resonance imaging in a patient with ICD. Pacing Clin Electrophysiol. 2005;28:336-338.
8. Sommer T, Naehle CP, Yang A, Zeijlemaker V, Hackenbroch M, Schmiedel A, Meyer C, Strach K, Skowasch D, Vahlhaus C, Litt H, Schild H. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 Tesla in the presence of cardiac PMs in non-PMdependent patients: a prospective study with 115 examinations. Circulation. 2006;114:1285-1292. (Pubitemid 44402054)
9. Levine GN, Gomes AS, Arai AE, Bluemke DA, Flamm SD, Kanal E, Manning WJ, Martin ET, Smith JM, Wilke N, Shellock FS. Safety of magnetic resonance imaging in patients with cardiovascular devices: an American Heart Association scientific statement from the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance. Circulation. 2007;116:2878-2891.
10. Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol. 2004;43:1315-1324. (Pubitemid 38452612)
11. Mollerus M, Albin G, Lipinski M, Lucca J. Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions. Europace. 2010;12:947-951.
12. Baker KB, Tkach JA, Nyenhuis JA, Phillips M, Shellock FG, Gonzalez- Martinez J, Rezai AR. Evaluation of specific absorption rate as a dosimeter of MRI-related implant heating. J Magn Reson Imaging. 2004; 20:315-320. (Pubitemid 38970942)
13. Karamitsos TD, Francis JM, Myerson S, Selvanayagam JB, Neubauer S. The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol. 2009;54:1407-1424.
14. McCrohon JA, Prasad SK, McKenna WJ, Lorenz CH, Coats AJS, Pennell DJ. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using galinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54-59. (Pubitemid 36859020)
15. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2002. (Pubitemid 29529292)
16. Nazarian S, Bluemke DA, Lardo AC, Zviman MM, Watkins SP, Dickfeld TL, Meininger GR, Roguin A, Calkins H, Tomaselli GF, Weiss RG, Berger RD, Lima JAC, Halperin HR. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation. 2005;112:2821-2825. (Pubitemid 41641676)
17. Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D, Lai S, Bluemke DA, Gerstenblith G, Marbán E, Tomaselli GF, Lima JA. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol. 2008;51:2414-2421. (Pubitemid 351826874)
18. Tandri H, Castillo E, Ferrari VA, Nasir K, Dalal D, Bomma C, Calkins H, Bluemke DA. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol. 2006;48:2277-2284. (Pubitemid 44855415)
19. Roes SD, Borleffs CJ, van der Geest RJ, Westenberg JJ, Marsan NA, Kaandorp TA, Reiber JH, Zeppenfeld K, Lamb HJ, de Roos A, Schalij MJ, Bax JJ. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and ICD. Circ Cardiovasc Imaging. 2009;2:183-190.
20. Cobelli FD, Pieroni M, Esposito A, Chimenti C, Belloni E, Mellone R, Canu T, Perseghin G, Gaudio C, Maseri A, Frustaci A, Maschio AD. Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol. 2006;47:1649-1654.
21. Cheong BYC, Muthupillai R, Wilson JM, Sung A, Huber S, Amin S, Elayda MA, Lee VV, Flamm SD. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation. 2009;120:2069-2076.
22. Bogun FM, Desjardins B, Good E, Gupta S, Crawford T, Oral H, Ebinger M, Pelosi F, Chugh A, Jongnarangsin K, Morady F. Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate. J Am Coll Cardiol. 2009;53:1138-1145.
23. Desjardins B, Crawford T, Good E, Oral H, Chugh A, Pelosi F, Morady F, Bogun F. Infarct architecture and characteristics on delayed enhanced magnetic resonance imaging and electroanatomic mapping in patients with postinfarction ventricular arrhythmia. Heart Rhythm. 2009;6:644-651.
24. Schueler BA, Parrish TB, Lin JC, Hammer BE, Pangrle BJ, Ritenour ER, Kucharczyk J, Truwit CL. MRI compatibility and visibility assessment of implantable medical devices. J Magn Reson Imaging. 1999;9:596-603. (Pubitemid 29194300)
25. Suh JS, Jeong EK, Shin KH, Cho JH, Na JB, Kim DH, Han CD. Minimizing artifacts caused by metallic implants at MR imaging: experimental and clinical studies. AJR Am J Roentgenol. 1998;171:1207-1213. (Pubitemid 28489398)
26. Stradiotti P, Curti A, Castellazzi G, Zerbi A. Metal-related artifacts in instrumented spine: techniques for reducing artifacts in CT and MRI: state of the art. Eur Spine J. 2009;18:102-108.
27. DiFilippo FP, Brunken RC. Do implanted PM leads and ICD leads metal-related artifact in cardiac PET/CT? J Nucl Med. 2005;46:436-443. (Pubitemid 43093152)
28. Eggers G, Rieker M, Kress B, Fiebach J, Dickhaus H, Hassfeld S. Artifacts in magnetic resonance imaging caused by dental material. MAGMA. 2005;18:103-111. (Pubitemid 40767701)